GO
Loading...

Mad Money Mail: Ironwood Pharma, Santarus & More

Thursday, 17 Jan 2013 | 6:45 PM ET

Ironwood Pharmaceuticals recently launched a drug called Linzess, and the company also reported an EPS loss; and Mad Money host Jim Cramer answers viewers' investment questions.